Target & Activity
| Target | Activity | Value |
|---|---|---|
| Reverse transcriptase |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| C8166 | CC50 | > 1000 μM | Toxicity in human C8166 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 31310115] |
| Caco-2 | IC50 | > 250 μM | Cytostatic activity against human Caco2 cells assessed as growth inhibition after 3 days by particle counting analysis | [PMID: 24177359] |
| CCRF-CEM | CC50 | > 100 μM | Cytotoxicity against human CEM cells assessed as reduction in cell viability by MTT assay | [PMID: 33421915] |
| CCRF-CEM | IC50 | > 100 μM | Cytotoxicity against human CEM cells after 6 days by trypan blue exclusion assay | [PMID: 21700368] |
| CCRF-CEM | CC50 | > 100 μM | Cytotoxicity against human CEM cells by CellTiter 96 non-radioactive cell proliferation colorimetric assay | [PMID: 28688280] |
| CCRF-CEM | CC50 | > 100 μM | Cytotoxicity against human CEM cells assessed as growth inhibition by CellTiter 96 non-radioactive cell proliferation colorimetric assay | [PMID: 28094179] |
| CCRF-CEM | IC50 | > 250 μM | Cytostatic activity against thymidine kinase-deficient human CEM cells assessed as growth inhibition after 3 days by particle counting analysis | [PMID: 24177359] |
| CCRF-CEM | IC50 | > 250 μM | Cytostatic activity against human CEM cells assessed as growth inhibition after 3 days by particle counting analysis | [PMID: 24177359] |
| CCRF-CEM | EC50 | 0.099 μM | Antiviral activity against HIV1 3B infected in human CEM cells assessed as virus-induced giant cell formation after 4 days by microscopic analysis | [PMID: 24177359] |
| CCRF-CEM | EC50 | 0.18 μM | Antiviral activity against HIV2 ROD infected in human CEM cells assessed as virus-induced giant cell formation after 4 days by microscopic analysis | [PMID: 24177359] |
| CCRF-CEM | IC50 | 50 μM | Compound was evaluated for cytotoxicity by inhibition of mitochondrial DNA synthesis | 10.1016/0960-894X(95)00343-R |
| CEM-SS | ED50 | 0.36 μM | Antiviral activity against HIV1 3B infected in human CEM-SS cells assessed as inhibition of virus-induced cytopathic effect after 6 days by MTS assay | [PMID: 15217281] |
| CEM-SS | EC50 | 200 nM | Antiviral activity against HIV-1 subtype 3B infected in CEM-SS cells assessed as inhibition of viral replication after 6 days by XTT assay | [PMID: 22858097] |
| CHO | IC50 | 54.2 μM | Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits | [PMID: 23812503] |
| COLO 320 | IC50 | > 250 μM | Cytostatic activity against human COLO320 cells assessed as growth inhibition after 3 days by particle counting analysis | [PMID: 24177359] |
| H9 | CC50 | > 200 μM | Cytotoxicity against human H9 cells assessed as cell viability incubated for 7 days by MTT colorimetric assay | [PMID: 34245947] |
| H9 | EC50 | 0.06 μM | Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of virus-induced cytopathic effect by formazan-based conventional colorimetric technique | [PMID: 11430019] |
| H9 | EC50 | 0.06 μM | Antiviral activity against HIV1 RF in human H9 cells assessed as inhibition of virus-induced cytopathic effect by formazan-based conventional colorimetric technique | [PMID: 11430019] |
| HEK293 | EC50 | > 300 μM | Antiviral activity against HIV1 expressing reverse transcriptase D67N/K70R/T215F/K219E/M184V mutant infected in HEK293 cells assessed as inhibition of virus replication after 72 hrs | [PMID: 20308377] |
19 records · Scroll to view more